NOONAN SYNDROME
Clinical trials for NOONAN SYNDROME explained in plain language.
Never miss a new study
Get alerted when new NOONAN SYNDROME trials appear
Sign up with your email to follow new studies for NOONAN SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tracking growth and health in kids with rare genetic condition
Disease control ENROLLING_BY_INVITATIONThis study is creating a French registry to collect information on children with Noonan Syndrome who are being treated with Norditropin®, a growth hormone. It aims to track their long-term growth, monitor safety, and understand how treatment affects their quality of life. The stu…
Matched conditions: NOONAN SYNDROME
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 01, 2026 18:41 UTC
-
Weekly shot aims to boost height in kids
Disease control OngoingThis study is testing a new, once-a-week growth hormone injection called somapacitan in children who are shorter than average. It includes kids born small, or with Turner syndrome, Noonan syndrome, or unexplained short stature. The main goals are to see if the treatment is safe a…
Matched conditions: NOONAN SYNDROME
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 01, 2026 18:40 UTC
-
New hope for families facing rare childhood illnesses
Symptom relief ENROLLING_BY_INVITATIONThis study is testing a support program called FACE-Rare for families caring for children with serious, rare diseases. The program aims to help identify and meet families' needs for support, improve caregivers' quality of life, and assist with planning for future medical decision…
Matched conditions: NOONAN SYNDROME
Phase: NA • Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC